Mednax Valuation
| MD Stock | USD 14.96 0.21 1.42% |
At this time, the firm appears to be undervalued. Mednax Inc secures a last-minute Real Value of $15.58 per share. The latest price of the firm is $14.96. Our model forecasts the value of Mednax Inc from analyzing the firm fundamentals such as Profit Margin of (0.13) %, current valuation of 1.75 B, and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mednax's valuation include:
Price Book 1.754 | Enterprise Value 1.7 B | Enterprise Value Ebitda 69.2712 | Price Sales 0.6401 | Forward PE 9.6618 |
Undervalued
Today
Please note that Mednax's price fluctuation is not too volatile at this time. Calculation of the real value of Mednax Inc is based on 3 months time horizon. Increasing Mednax's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mednax stock is determined by what a typical buyer is willing to pay for full or partial control of Mednax Inc. Since Mednax is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mednax Stock. However, Mednax's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.96 | Real 15.58 | Target 14.5 | Hype 14.94 | Naive 13.65 |
The real value of Mednax Stock, also known as its intrinsic value, is the underlying worth of Mednax Inc Company, which is reflected in its stock price. It is based on Mednax's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mednax's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mednax Inc helps investors to forecast how Mednax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mednax more accurately as focusing exclusively on Mednax's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mednax's intrinsic value based on its ongoing forecasts of Mednax's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mednax's closest peers. If more than one evaluation category is relevant for Mednax we suggest using both methods to arrive at a better estimate.
Mednax Cash |
|
Mednax Valuation Trend
Comparing Mednax's enterprise value against its market capitalization is a good way to estimate the value of Mednax Inc uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Mednax Revenue by Product
Mednax Total Value Analysis
Mednax Inc is now forecasted to have takeover value of 1.75 B with market capitalization of 1.28 B, debt of 701.65 M, and cash on hands of 9.82 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Mednax fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.75 B | 1.28 B | 701.65 M | 9.82 M |
Mednax Investor Information
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednax Inc has Price/Earnings To Growth (PEG) ratio of 0.88. The entity recorded a loss per share of 2.34. The firm had not issued any dividends in recent years. Mednax had 2:1 split on the 20th of December 2013. Based on the key measurements obtained from Mednax's financial statements, Mednax Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0035 | 0.0037 |
|
| |||||
| Total Cash From Operating Activities | 210.1 M | 137.3 M |
|
| |||||
| Operating Income | 7 M | 7.3 M |
|
|
Mednax Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mednax has an asset utilization ratio of 89.86 percent. This indicates that the Company is making $0.9 for each dollar of assets. An increasing asset utilization means that Mednax Inc is more efficient with each dollar of assets it utilizes for everyday operations.Mednax Ownership Allocation
The majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company.Mednax Profitability Analysis
The company generated the yearly revenue of 1.99 B. Annual Net Loss to common stockholders was (60.41 M) with gross profit of 467.03 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mednax's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mednax and how it compares across the competition.
About Mednax Valuation
The stock valuation mechanism determines Mednax's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mednax. We calculate exposure to Mednax's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mednax's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 421.6 M | 542.2 M | |
| Pretax Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.03) | (0.03) | |
| Gross Profit Margin | 0.21 | 0.20 |
Mednax Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mednax does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 82.2 M | |
| Quarterly Earnings Growth Y O Y | -0.112 | |
| Forward Price Earnings | 9.6618 |
Mednax Current Valuation Indicators
Valuation refers to the process of determining the present value of Mednax Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mednax we look at many different elements of the entity such as Mednax's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mednax, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mednax's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mednax's worth.Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |